The biotech news stories you need to read today
The risk of pharma bribery, the risk of brain drain, and other risks (and rewards) in the biotech landscape this week.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hey there, it’s Meghana. Today, we consider whether international pharma bribery will increase in the wake of a new Trump administration executive order, highlight concerns from the scientific community that an academic brain drain — particularly among younger researchers — is impending, and more.
